- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 864-878 of
973 results
1106 Exhibit: Exhibit 1106 Wegovy label
Document
IPR2023-00724, No. 1106 Exhibit - Exhibit 1106 Wegovy label (P.T.A.B. May. 22, 2024)
|
|
Cite Document
2515 Exhibit: EX2515 Novo Nordisk, Financial report for the period 1 January 2023...
Document
IPR2023-00724, No. 2515 Exhibit - EX2515 Novo Nordisk, Financial report for the period 1 January 2023 to 30 June 2023 Aug 10, 2023 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2400 Exhibit: EX2400 Janumet® Prescribing Information rev Feb 2018
Document
IPR2023-00724, No. 2400 Exhibit - EX2400 Janumet® Prescribing Information rev Feb 2018 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2412 Exhibit: EX2412 US Food Drug Administration, DrugsFDA, Kombiglyze® XR
Document
IPR2023-00724, No. 2412 Exhibit - EX2412 US Food Drug Administration, DrugsFDA, Kombiglyze® XR (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2366 Exhibit: EX2366 Cleveland Clinic, “Biguanides,” httpsmyclevelandclinicorghea...
Document
IPR2023-00724, No. 2366 Exhibit - EX2366 Cleveland Clinic, “Biguanides,” httpsmyclevelandclinicorghealthtreatments25004 biguanides, last reviewed May 22, 2023 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2074 Exhibit: EX2074 Ozempic® Prescribing Information Australian Product Inform...
Document
IPR2023-00724, No. 2074 Exhibit - EX2074 Ozempic® Prescribing Information Australian Product Information December 2020 available at httpswwwnovonordiskcomaucontentdamnncorpauenp...
|
|
Cite Document
2442 Exhibit: EX2442 Invokamet® Prescribing Information rev Aug 2017
Document
IPR2023-00724, No. 2442 Exhibit - EX2442 Invokamet® Prescribing Information rev Aug 2017 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2556 Exhibit: EX2556 Transcript of July 26, 2024 Deposition of Allen Spiegel, MD
Document
IPR2023-00724, No. 2556 Exhibit - EX2556 Transcript of July 26, 2024 Deposition of Allen Spiegel, MD (P.T.A.B. Aug. 5, 2024)
|
|
Cite Document
2540 Exhibit: EX2540 Email Exchange Between Counsel for Petitioner and Counse...
Document
IPR2023-00724, No. 2540 Exhibit - EX2540 Email Exchange Between Counsel for Petitioner and Counsel for Patent Owner Regarding Request for a Sotera Stipulation (P.T.A.B. Jul. 31, 2024)
|
|
Cite Document
1139 Exhibit: Exhibit 1139 Lorenz
Document
IPR2023-00724, No. 1139 Exhibit - Exhibit 1139 Lorenz (P.T.A.B. May. 22, 2024)
|
|
Cite Document
1107 Exhibit: Exhibit 1107 Wegovy Orange book
Document
IPR2023-00724, No. 1107 Exhibit - Exhibit 1107 Wegovy Orange book (P.T.A.B. May. 22, 2024)
|
|
Cite Document
1091 Exhibit: Bloodworth Declaration
Document
IPR2023-00724, No. 1091 Exhibit - Bloodworth Declaration (P.T.A.B. Dec. 18, 2023)
|
|
Cite Document
2008 Exhibit: EX2008 Ozempic®, Prescribing Information October 2022
Document
IPR2023-00724, No. 2008 Exhibit - EX2008 Ozempic®, Prescribing Information October 2022 (P.T.A.B. Jul. 6, 2023)
|
|
Cite Document
1029 Exhibit: Jimenez Solem 2010
Document
IPR2023-00724, No. 1029 Exhibit - Jimenez Solem 2010 (P.T.A.B. Mar. 16, 2023)
|
|
Cite Document
1037 Exhibit: Nielsen 2004
Document
IPR2023-00724, No. 1037 Exhibit - Nielsen 2004 (P.T.A.B. Mar. 16, 2023)
|
|
Cite Document
